College of
Human
Medicine

News Archive (2009)

MSU College of Human Medicine welcomes Parkinson’s Disease researcher

July 2009

The collaborative efforts of Michigan State University College of Human Medicine and the Van Andel Institute have resulted in another top scientific research recruit for Michigan’s life sciences corridor.

Jack Lipton, Ph.D., a distinguished researcher in the areas of prenatal exposure to drugs of abuse and Parkinson’s Disease has been appointed Chair of the Division of Translational Science and Molecular Medicine for the College of Human Medicine and will be responsible for recruiting a team of neuroscientists whose focus is Parkinson’s Disease. Funding for Dr. Lipton’s position was made possible through the college’s partnership with the Van Andel Institute. 

“Van Andel Research Institute is looking forward to the arrival of Dr. Lipton and his team of researchers. Their expertise will enhance our region’s focus on Parkinson’s Disease research. The collaborative research environment developing in Grand Rapids should facilitate Dr. Lipton’s efforts to recruit other world-class scientists,” stated Dr. Jeffrey Trent, President and Research Director of Van Andel Research Institute and Translational Genomics Research Institute. 

Dr. Lipton is currently a Professor and Director of the Division of Neuropharmacology in the Department of Psychiatry at the University of Cincinnati College of Medicine. Prior to that Dr. Lipton was a faculty member in the Departments of Neurology and Pharmacology at Rush University Medical Center in Chicago, Illinois. He earned his Master of Arts and Doctor of Philosophy degrees in Behavioral Neuroscience at the University of California, Los Angeles. 

Dr. Lipton’s lab will be located at the Van Andel Institute when he begins his post in the coming months.

###